X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Vanta Bioscience Ltd.
BSE CODE: 540729   |   NSE CODE: NA   |   ISIN CODE : INE695X01011   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 43.07
2 ( 4.87% )
 
Prev Close ( Rs.)
41.07
Open ( Rs.)
43.07
 
High ( Rs.)
43.07
Low ( Rs.)
43.07
 
Volume
750
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.08  -6.71  0.12  0.75  1.55  
   CEPS(Rs)2.04  -4.73  2.21  2.73  3.43  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)31.36  31.28  38.01  37.88  37.14  
   Tax Rate(%)-22.45  -0.67  43.78  22.27  24.07  
Margin Ratios          
   Core EBITDA Margin(%)42.68  -9.20  36.38  38.79  30.58  
   EBIT Margin(%)28.79  -21.28  24.10  26.53  22.93  
   Pre Tax Margin(%)0.49  -81.36  1.49  6.03  9.13  
   PAT Margin (%)0.60  -81.91  0.84  4.68  6.93  
   Cash Profit Margin (%)15.04  -57.73  14.92  17.15  15.35  
Performance Ratios          
   ROA(%)0.10  -8.30  0.16  1.07  2.45  
   ROE(%)0.26  -19.37  0.33  1.99  4.28  
   ROCE(%)5.43  -2.44  5.24  6.76  8.86  
   Asset Turnover(x)0.16  0.10  0.19  0.23  0.35  
   Sales/Fixed Asset(x)0.19  0.12  0.25  0.36  0.67  
   Working Capital/Sales(x)-3.93  5.84  9.17  3.77  1.36  
Efficiency Ratios          
   Fixed Capital/Sales(x)5.20  8.20  3.97  2.81  1.50  
   Receivable days90.86  93.40  52.75  60.64  37.76  
   Inventory Days312.25  507.98  331.82  432.17  300.67  
   Payable days3147.02  1023.32  565.86  213.02  146.72  
Valuation Parameters          
   PER(x)791.10  0.00  883.04  218.76  58.73  
   PCE(x)31.39  -12.16  49.72  59.76  26.51  
   Price/Book(x)2.04  1.84  2.89  4.30  2.45  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)7.67  11.99  9.63  12.24  5.21  
   EV/Core EBITDA(x)17.74  413.82  25.22  30.68  16.16  
   EV/EBIT(x)26.64  -56.32  39.96  45.09  22.09  
   EV/CE(x)1.45  1.36  1.78  2.59  1.71  
   M Cap / Sales4.72  7.02  7.42  10.48  4.19  
Growth Ratio          
   Net Sales Growth(%)65.50  -44.69  -4.74  -28.48  13.61  
   Core EBITDA Growth(%)2370.04  -95.80  -8.83  -11.53  26.54  
   EBIT Growth(%)323.89  -148.84  -15.40  -17.70  16.16  
   PAT Growth(%)101.21  -5495.52  -83.31  -51.91  40.97  
   EPS Growth(%)101.21  -5494.05  -83.30  -51.91  40.97  
Financial Stability Ratios          
   Total Debt/Equity(x)1.28  1.30  0.87  0.72  0.60  
   Current Ratio(x)0.85  1.09  1.10  1.24  2.42  
   Quick Ratio(x)0.32  0.39  0.38  0.35  0.50  
   Interest Cover(x)1.02  -0.35  1.07  1.29  1.66  
   Total Debt/Mcap(x)0.63  0.71  0.30  0.17  0.25